[Form 4] ACM Research, Inc. Insider Trading Activity
The reporting person, Cheav Sotheara, exercised a previously issued stock option and immediately sold the acquired shares. On 08/22/2025 Mr. Cheav exercised an option with a $13.89 exercise price to purchase 11,152 shares of ACM Research Class A common stock and sold 11,152 shares that same day at $30 per share pursuant to a Rule 10b5-1 trading plan adopted May 15, 2025. After these transactions the reporting person beneficially owns 100,002 shares of Class A common stock. The Form 4 notes the underlying option covers 66,250 shares, is fully vested and exercisable, and includes a vesting schedule for remaining tranches. The reporting person is identified as Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc., a subsidiary of the issuer.
La persona che ha presentato la segnalazione, Cheav Sotheara, ha esercitato un'opzione su azioni precedentemente concessa e ha venduto immediatamente le azioni acquisite. In data 22/08/2025 il Sig. Cheav ha esercitato un'opzione con prezzo di esercizio di $13,89 per acquistare 11.152 azioni di ACM Research Class A common stock e, nello stesso giorno, ha venduto 11.152 azioni a $30 ciascuna in conformit脿 a un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 15 maggio 2025. Dopo queste operazioni la persona che ha segnalato detiene beneficiariamente 100.002 azioni di classe A. Il Modulo 4 indica che l'opzione sottostante copre 66.250 azioni, 猫 completamente maturata ed esercitabile, e include un calendario di vesting per le tranche rimanenti. La persona che ha segnalato 猫 identificata come Senior Vice President, Manufacturing di ACM Research (Shanghai), Inc., controllata dell'emittente.
La persona informante, Cheav Sotheara, ejerci贸 una opci贸n sobre acciones previamente otorgada y vendi贸 de inmediato las acciones adquiridas. El 22/08/2025 el Sr. Cheav ejerci贸 una opci贸n con precio de ejercicio de $13.89 para comprar 11.152 acciones de ACM Research Class A common stock y vendi贸 las 11.152 acciones ese mismo d铆a a $30 por acci贸n conforme a un plan de negociaci贸n bajo la Regla 10b5-1 adoptado el 15 de mayo de 2025. Tras estas operaciones, la persona informante posee a t铆tulo beneficiario 100.002 acciones de la clase A. El Formulario 4 se帽ala que la opci贸n subyacente cubre 66.250 acciones, est谩 totalmente consolidada y ejercitable, e incluye un calendario de vesting para las tramas restantes. La persona informante est谩 identificada como Senior Vice President, Manufacturing de ACM Research (Shanghai), Inc., subsidiaria del emisor.
鞁犼碃鞚� Cheav Sotheara電� 鞚挫爠鞐� 攵�鞐悳 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橁碃 歃夓嫓 旆摑頃� 欤检嫕鞚� 毵る弰頄堨姷雼堧嫟. 2025雲� 8鞗� 22鞚� Cheav 鞌姅 頄夓偓臧�瓴� $13.89鞚� 鞓奠厴鞚� 頄夓偓頃橃棳 ACM Research Class A 氤错喌欤� 11,152欤茧ゼ 旆摑頄堨溂氅�, 臧欖潃 雮� 2025雲� 5鞗� 15鞚� 毂勴儩霅� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 欤茧嫻 $30鞐� 11,152欤茧ゼ 毵る弰頄堨姷雼堧嫟. 鞚� 瓯半灅霌� 鞚错泟 鞁犼碃鞚胳潃 Class A 氤错喌欤� 100,002欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. Form 4鞐愲姅 旮办磮 鞓奠厴鞚� 66,250欤茧ゼ 韽暔頃橂┌ 鞕勳爠頌� 氩犾姢韺呺悩鞏� 頄夓偓 臧�電ロ晿瓿�, 雮潃 韸鸽灉旃橃棎 雽�頃� 氩犾姢韺� 鞚检爼鞚� 韽暔霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 氚滍枆須岇偓鞚� 鞛愴殞靷澑 ACM Research (Shanghai), Inc.鞚� 靸濎偘雼措嫻 靾橃劃攵�靷灔(Senior Vice President, Manufacturing)鞙茧 鞁濍硠霅╇媹雼�.
La personne d茅clarente, Cheav Sotheara, a exerc茅 une option d'achat d'actions pr茅alablement accord茅e et a imm茅diatement vendu les actions obtenues. Le 22/08/2025, M. Cheav a exerc茅 une option au prix d'exercice de 13,89 $ pour acqu茅rir 11 152 actions ordinaires de classe A d'ACM Research, et a vendu ces 11 152 actions le m锚me jour 脿 30 $ l'action, conform茅ment 脿 un plan de n茅gociation en vertu de la Rule 10b5-1 adopt茅 le 15 mai 2025. 脌 la suite de ces op茅rations, la personne d茅clarente d茅tient 脿 titre b茅n茅ficiaire 100 002 actions de classe A. Le formulaire 4 indique que l'option sous-jacente couvre 66 250 actions, est enti猫rement acquise et exer莽able, et comprend un calendrier d'acquisition pour les tranches restantes. La personne d茅clarente est identifi茅e comme Senior Vice President, Manufacturing d'ACM Research (Shanghai), Inc., une filiale de l'茅metteur.
Die meldende Person, Cheav Sotheara, hat eine zuvor ausgestellte Aktienoption ausge眉bt und die erworbenen Aktien sofort verkauft. Am 22.08.2025 眉bte Herr Cheav eine Option mit einem Aus眉bungspreis von $13,89 zum Kauf von 11.152 Aktien der ACM Research Class A Stammaktien und verkaufte am selben Tag 11.152 Aktien zu je $30 gem盲脽 einem am 15. Mai 2025 angenommenen Rule-10b5-1-Handelsplan. Nach diesen Transaktionen h盲lt die meldende Person wirtschaftlich 100.002 Class-A-Aktien. Im Formular 4 wird angegeben, dass die zugrundeliegende Option 66.250 Aktien umfasst, vollst盲ndig unverfallbar und aus眉bbar ist und einen Vestingplan f眉r verbleibende Tranchen enth盲lt. Die meldende Person ist als Senior Vice President, Manufacturing von ACM Research (Shanghai), Inc., einer Tochtergesellschaft des Emittenten, aufgef眉hrt.
- None.
- None.
Insights
TL;DR: Insider exercised options and sold shares under a pre-established 10b5-1 plan; change in beneficial ownership is disclosed.
The filing discloses a routine Section 16 transaction: exercise of an option at $13.89 for 11,152 shares followed by an immediate sale of the same number of shares at $30 under a Rule 10b5-1 plan adopted May 15, 2025. The filing reports 100,002 shares beneficially owned after the transactions and identifies the reporting persons role within a subsidiary. This is a transparent disclosure of insider liquidity rather than a corporate operational event.
TL;DR: Proper Form 4 disclosure of option exercise and 10b5-1 plan sale; documentation of vesting and beneficial ownership provided.
The Form 4 provides required detail: transaction codes, prices, quantities, and an explanation that the sale was effected pursuant to a 10b5-1 plan. It also describes the options vesting schedule and states the option is fully vested and exercisable. Signatory is an attorney-in-fact, indicating authorized filing. From a governance perspective the filing meets disclosure expectations for insider transactions.
La persona che ha presentato la segnalazione, Cheav Sotheara, ha esercitato un'opzione su azioni precedentemente concessa e ha venduto immediatamente le azioni acquisite. In data 22/08/2025 il Sig. Cheav ha esercitato un'opzione con prezzo di esercizio di $13,89 per acquistare 11.152 azioni di ACM Research Class A common stock e, nello stesso giorno, ha venduto 11.152 azioni a $30 ciascuna in conformit脿 a un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 15 maggio 2025. Dopo queste operazioni la persona che ha segnalato detiene beneficiariamente 100.002 azioni di classe A. Il Modulo 4 indica che l'opzione sottostante copre 66.250 azioni, 猫 completamente maturata ed esercitabile, e include un calendario di vesting per le tranche rimanenti. La persona che ha segnalato 猫 identificata come Senior Vice President, Manufacturing di ACM Research (Shanghai), Inc., controllata dell'emittente.
La persona informante, Cheav Sotheara, ejerci贸 una opci贸n sobre acciones previamente otorgada y vendi贸 de inmediato las acciones adquiridas. El 22/08/2025 el Sr. Cheav ejerci贸 una opci贸n con precio de ejercicio de $13.89 para comprar 11.152 acciones de ACM Research Class A common stock y vendi贸 las 11.152 acciones ese mismo d铆a a $30 por acci贸n conforme a un plan de negociaci贸n bajo la Regla 10b5-1 adoptado el 15 de mayo de 2025. Tras estas operaciones, la persona informante posee a t铆tulo beneficiario 100.002 acciones de la clase A. El Formulario 4 se帽ala que la opci贸n subyacente cubre 66.250 acciones, est谩 totalmente consolidada y ejercitable, e incluye un calendario de vesting para las tramas restantes. La persona informante est谩 identificada como Senior Vice President, Manufacturing de ACM Research (Shanghai), Inc., subsidiaria del emisor.
鞁犼碃鞚� Cheav Sotheara電� 鞚挫爠鞐� 攵�鞐悳 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橁碃 歃夓嫓 旆摑頃� 欤检嫕鞚� 毵る弰頄堨姷雼堧嫟. 2025雲� 8鞗� 22鞚� Cheav 鞌姅 頄夓偓臧�瓴� $13.89鞚� 鞓奠厴鞚� 頄夓偓頃橃棳 ACM Research Class A 氤错喌欤� 11,152欤茧ゼ 旆摑頄堨溂氅�, 臧欖潃 雮� 2025雲� 5鞗� 15鞚� 毂勴儩霅� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 欤茧嫻 $30鞐� 11,152欤茧ゼ 毵る弰頄堨姷雼堧嫟. 鞚� 瓯半灅霌� 鞚错泟 鞁犼碃鞚胳潃 Class A 氤错喌欤� 100,002欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. Form 4鞐愲姅 旮办磮 鞓奠厴鞚� 66,250欤茧ゼ 韽暔頃橂┌ 鞕勳爠頌� 氩犾姢韺呺悩鞏� 頄夓偓 臧�電ロ晿瓿�, 雮潃 韸鸽灉旃橃棎 雽�頃� 氩犾姢韺� 鞚检爼鞚� 韽暔霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 氚滍枆須岇偓鞚� 鞛愴殞靷澑 ACM Research (Shanghai), Inc.鞚� 靸濎偘雼措嫻 靾橃劃攵�靷灔(Senior Vice President, Manufacturing)鞙茧 鞁濍硠霅╇媹雼�.
La personne d茅clarente, Cheav Sotheara, a exerc茅 une option d'achat d'actions pr茅alablement accord茅e et a imm茅diatement vendu les actions obtenues. Le 22/08/2025, M. Cheav a exerc茅 une option au prix d'exercice de 13,89 $ pour acqu茅rir 11 152 actions ordinaires de classe A d'ACM Research, et a vendu ces 11 152 actions le m锚me jour 脿 30 $ l'action, conform茅ment 脿 un plan de n茅gociation en vertu de la Rule 10b5-1 adopt茅 le 15 mai 2025. 脌 la suite de ces op茅rations, la personne d茅clarente d茅tient 脿 titre b茅n茅ficiaire 100 002 actions de classe A. Le formulaire 4 indique que l'option sous-jacente couvre 66 250 actions, est enti猫rement acquise et exer莽able, et comprend un calendrier d'acquisition pour les tranches restantes. La personne d茅clarente est identifi茅e comme Senior Vice President, Manufacturing d'ACM Research (Shanghai), Inc., une filiale de l'茅metteur.
Die meldende Person, Cheav Sotheara, hat eine zuvor ausgestellte Aktienoption ausge眉bt und die erworbenen Aktien sofort verkauft. Am 22.08.2025 眉bte Herr Cheav eine Option mit einem Aus眉bungspreis von $13,89 zum Kauf von 11.152 Aktien der ACM Research Class A Stammaktien und verkaufte am selben Tag 11.152 Aktien zu je $30 gem盲脽 einem am 15. Mai 2025 angenommenen Rule-10b5-1-Handelsplan. Nach diesen Transaktionen h盲lt die meldende Person wirtschaftlich 100.002 Class-A-Aktien. Im Formular 4 wird angegeben, dass die zugrundeliegende Option 66.250 Aktien umfasst, vollst盲ndig unverfallbar und aus眉bbar ist und einen Vestingplan f眉r verbleibende Tranchen enth盲lt. Die meldende Person ist als Senior Vice President, Manufacturing von ACM Research (Shanghai), Inc., einer Tochtergesellschaft des Emittenten, aufgef眉hrt.
FAQ
What did ACMR insider Cheav Sotheara do on 08/22/2025?
Were the sales made under a trading plan for ACMR insider Cheav Sotheara?
How many ACMR shares does the reporting person own after the transactions?
What are the terms of the option disclosed in the Form 4?
What is the reporting persons role at ACM Research?
